Arteris, Inc. (NASDAQ:AIP) Sees Significant Increase in Short Interest

Arteris, Inc. (NASDAQ:AIP) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 356,200 shares, an increase of 15.6% from the December 31st total of 308,100 shares. Based on an average trading volume of 204,000 shares, the short-interest ratio is presently 1.7 days. Approximately 1.4% of the company’s shares are sold short.

Insider Activity

In other Arteris news, CFO Nicholas B. Hawkins sold 19,299 shares of the business’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $8.14, for a total transaction of $157,093.86. Following the transaction, the chief financial officer now directly owns 192,414 shares of the company’s stock, valued at approximately $1,566,249.96. The trade was a 9.12 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO K Charles Janac sold 17,856 shares of the firm’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $10.12, for a total transaction of $180,702.72. Following the completion of the sale, the chief executive officer now directly owns 10,287,435 shares of the company’s stock, valued at approximately $104,108,842.20. This represents a 0.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 325,456 shares of company stock valued at $3,355,352. Insiders own 33.70% of the company’s stock.

Institutional Trading of Arteris

A number of hedge funds have recently made changes to their positions in the stock. US Bancorp DE bought a new position in Arteris during the 3rd quarter valued at approximately $34,000. R Squared Ltd bought a new position in shares of Arteris during the fourth quarter valued at $64,000. Renaissance Technologies LLC raised its position in shares of Arteris by 6.1% in the 2nd quarter. Renaissance Technologies LLC now owns 114,700 shares of the company’s stock worth $861,000 after purchasing an additional 6,600 shares during the last quarter. MetLife Investment Management LLC boosted its stake in Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after purchasing an additional 9,551 shares in the last quarter. Finally, The Manufacturers Life Insurance Company purchased a new stake in Arteris during the 2nd quarter valued at about $86,000. 64.36% of the stock is owned by institutional investors.

Arteris Trading Up 3.9 %

NASDAQ:AIP opened at $11.21 on Friday. The firm has a market capitalization of $450.42 million, a P/E ratio of -11.68 and a beta of 1.17. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. Arteris has a one year low of $5.76 and a one year high of $12.64. The company’s 50-day simple moving average is $10.28 and its 200 day simple moving average is $8.56.

Analysts Set New Price Targets

Separately, Rosenblatt Securities reiterated a “buy” rating and set a $15.00 target price on shares of Arteris in a report on Wednesday, November 6th.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.